RELATIONSHIPS BETWEEN LIPOPROTEIN(A), LIPIDS, APOLIPOPROTEINS, BASAL AND STIMULATED FIBRINOLYTIC REGULATORS, AND D-DIMER

被引:95
作者
GLUECK, CJ
GLUECK, HI
TRACY, T
SPEIRS, J
MCCRAY, C
STROOP, D
机构
[1] JEWISH HOSP CINCINNATI,CLIN CHEM LAB,CINCINNATI,OH 45229
[2] UNIV CINCINNATI,COLL MED,DEPT PATHOL,CINCINNATI,OH 45221
[3] UNIV CINCINNATI,COLL MED,DEPT LAB MED,CINCINNATI,OH 45221
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1993年 / 42卷 / 02期
基金
英国医学研究理事会;
关键词
D O I
10.1016/0026-0495(93)90042-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 191 newly referred hyperlipidemic patients, our specific aim was to assess relationships between levels of lipoprotein(a) [Lp(a)], lipids, apolipoproteins, regulators of basal and stimulated fibrinolytic activity, and d-dimer, a measure of in vivo fibrinolysis. Lp(a) levels correlated with none of the measures of basal fibrinolytic regulators or d-dimer. In 25 patients, levels of stimulated regulators of fibrinolytic activity and d-dimer were measured after 10-minute cuff venous occlusion. Lp(a) levels again correlated with none of the stimulated regulators of fibrinolytic activity or d-dimer. However, both basal and stimulated levels of fibrinolytic regulators and d-dimer were closely related to other major risk factors for coronary heart disease (CHD) including triglyceride, apolipoprotein (apo) A1, apo B, Quetelet index (QI), and sex. By stepwise regression in 191 patients, the following standardized partial regression coefficients were significant (P ≤ .05), and model R2 and P values were as follows: basal tissue plasminogen activator (tPA) with apo B -.18, with time .17, with QI -.28, R2 = 17%, P ≤ .0001; basal plasminogen activator inhibitor (PAI) with apo B. .25, with time -.15, with QI .17, R2 = 14%, P ≤ .0001; basal α2-antiplasmin with apo A1 .14, with apo B .24, with QI .17, with sex .30, R2 = 25%, P < .0001; basal plasminogen with apo A1 .15, with apo B .21, with QI .17, with sex .17, R2 = 15%, P ≤ .0001; basal fibrinogen with Lp(a) .17, with QI .21, with sex .26, R2 = 14%, P ≤ .0001; d-dimer with sex .15, R2 = 21%, P ≤ .048. Given the absence of any relationship between Lp(a) levels and inhibition or stimulation of fibrinolysis regulators or d-dimer either in the basal or stimulated state, we postulate that Lp(a)'s major atherogenic effects are mediated by mechanisms other than reduction of fibrinolysis stimulation or in vivo fibrinolysis. © 1993.
引用
收藏
页码:236 / 246
页数:11
相关论文
共 76 条
  • [1] ALBERS JJ, 1977, J LIPID RES, V18, P331
  • [2] LP(A) LIPOPROTEIN - RELATIONSHIP TO SINKING PRE-BETA LIPOPROTEIN, HYPERLIPOPROTEINEMIA, AND APOLIPOPROTEIN-B
    ALBERS, JJ
    CABANA, VG
    WARNICK, GR
    HAZZARD, WR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (09): : 1047 - 1054
  • [3] IMMUNOCHEMICAL QUANTIFICATION OF HUMAN PLASMA LP(A) LIPOPROTEIN
    ALBERS, JJ
    HAZZARD, WR
    [J]. LIPIDS, 1974, 9 (01) : 15 - 26
  • [4] THE INCREASED PLASMA LP(A) - B-LIPOPROTEIN PARTICLE CONCENTRATION IN ANGINA-PECTORIS IS NOT ASSOCIATED WITH HYPOFIBRINOLYSIS
    ALESSI, MC
    PARRA, HJ
    JOLY, P
    VUDAC, N
    BARD, JM
    FRUCHART, JC
    JUHANVAGUE, I
    [J]. CLINICA CHIMICA ACTA, 1990, 188 (02) : 119 - 127
  • [5] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [6] ANDERSEN P, 1990, THROMB HAEMOSTASIS, V63, P174
  • [7] ANDERSEN P, 1981, ACTA MED SCAND, V209, P199
  • [8] THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS
    ARMSTRONG, VW
    CREMER, P
    EBERLE, E
    MANKE, A
    SCHULZE, F
    WIELAND, H
    KREUZER, H
    SEIDEL, D
    [J]. ATHEROSCLEROSIS, 1986, 62 (03) : 249 - 257
  • [9] ASSMANN G, 1983, CLIN CHEM, V29, P2026
  • [10] AVELLONE G, 1988, INT ANGIOL, V7, P270